Later this month, we'll be at the Transmission & Interconnection Summit presented by @infocast_events in Washington D.C., where partner Matthew Christiansen and associate Sarah Greenberg will be moderating panels.
Learn more: https://t.co/1LSomk9vu4
On the NextGen VC Podcast, Suman Rao of @LumiraVentures discusses her path from academic science to healthcare VC, investing outside traditional biotech hubs, & the $2.25B exit that shaped Lumira's next thesis.
Produced in collaboration with @LaunchBio: https://t.co/meAvNOnLzE
🎉🤝Two incredible days at #MDC2026 in #SanFrancisco! Thank you to everyone who joined us and helped make this year's conference such a success.
We'll see you next year, MDC!
We're excited to co-host the webinar, “Inside the Deal: How GCs and Their Teams Actually Run M&A,” with @thelsuite_co. On 6/16, partner Mark Holloway will join the panel to explore how general counsel and their deputies operate during live transactions.
https://t.co/IEoqXAU1xL
Next week kicks off our Third Annual Rome Conference on AI, Ethics and Governance!
We are grateful for the partnership of our sponsors & supporting organizations.
⏰ There’s still time to join us. Registration closes this Thursday, June 11: https://t.co/qcx816waZV
#RomeAI2026
We are pleased to be supporting @EPPIC_GLOBAL's upcoming program "Power of Single-Cell-Multi-Omics: From Bench to Bedside," hosted at MBC BioLabs in San Carlos.
Learn more about the event and how to register to attend: https://t.co/Er7xz8yKKn
This Thursday, partner Demian Ahn will be moderating the panel, "US@War: Executive Perspectives on Cyber Risk," hosted by the @UofMaryland's Smith Enterprise Risk Consortium.
Learn more and register for the webinar: https://t.co/23yGpM8SBQ
Last week, Digital Health partner Jodi Daniel joined Second Opinion Media’s @chrissyfarr for the live webinar "Privacy, AI & the Future of HIPAA with the Former Founding Director of ONC."
If you missed the live taping, you can view the recording on-demand ⬇️
The EC released its first draft of a proposed Cloud and AI Development Act, marking a significant step forward in the EU’s efforts to strengthen its digital infrastructure and reduce strategic dependence on non-EU cloud providers.
Learn more: https://t.co/x20C2mz439
Authors Demian Ahn, Colin Black, Laura Brodahl & Tony Misher outline compliance and incident response implications from the YellowKey Zero-Day and the BitLocker Bypass: https://t.co/92OLWiSW3P
Congratulations to our client @Cloudflare on the acquisition of VoidZero, an open source-first company behind the next-generation JavaScript tooling ecosystem Vite!
Learn more about the Wilson Sonsini team involved in the transaction: https://t.co/EVq0Hduly9
VoidZero, the team behind Vite, Vitest, Rolldown, Oxc, and Vite+, is joining Cloudflare. Vite stays open source, vendor-agnostic, and built for everyone. https://t.co/DJTpX4Q9Xt
Last month, the Connecticut legislature passed two bills that amend and expand the Connecticut Data Privacy Act (CTDPA): Senate Bill 4 (SB 4) and House Bill 5222 (HB 5222).
Learn more from our Data Advisor authors: https://t.co/knRHf2AK7o
🏆 We're honored to share that the 2026 @ChambersGuides USA guide has recognized Wilson Sonsini as a leading law firm in 44 geography-specific practice categories and named 87 Wilson Sonsini attorneys among the best in their fields!
https://t.co/NM00ludcgM
🎉 Congratulations to firm client @IsomorphicLabs on the $2.1 billion Series B investment round! A Wilson Sonsini team led by Allison Spinner and Andy Gillman was pleased to advise Isomorphic on the transaction.
🔗 Learn more about the transaction: https://t.co/LMxCXu6IAS
Today marks a pivotal moment for Isomorphic Labs. We have secured $2.1 Billion in our second external funding round, led by Thrive Capital. They are joined at the table by Alphabet, GV and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund.
This milestone accelerates our ability to build the pioneering novel AI models that power our AI drug design engine (IsoDDE) and deploy them at scale: delivering scientific breakthroughs with a precision previously thought impossible, accelerating and expanding our pipeline of therapeutic programs toward the clinic. All with the ultimate goal of delivering life-changing new medicines to patients.
Moving forward, we will scale our drug candidate pipelines across multiple therapeutic areas, expand our global footprint, and push the boundaries of frontier AI research to power our drug design engine.
Deeply grateful to everyone sharing our vision to solve all disease with AI. Let’s build the future of medicine.
Read the full announcement here: https://t.co/TtXk3xqA84
👏 A Wilson Sonsini team led by Rich Mullen and Kaleigh Hawkins-Schulz was pleased to advise @asana on its acquisition of @stackai!
To learn more about the advising team and transaction, visit: https://t.co/qTTKVwQ2C0
🥳 This week, Wilson Sonsini partner Jason Breen was named among @LABJnews' 2026 "Leaders of Influence: M&A," recognizing the LA region's top M&A experts and thought leaders for their leadership, skill, and achievements in the realm of M&A.
🔗: https://t.co/JgS47fmoTb